Form 4 holding
Senior Vice-President & CFO
SUPERNUS PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 9,129
- Estimated value
- $424,589
- Report date
- 12 Aug 2026
- Price
- $46.51
- Ownership
- Direct
Timothy C. Dec - Senior Vice-President & CFO at SUPERNUS PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- Senior Vice-President & CFO
- Issuer ticker
- SUPN on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Timothy C. Dec since 23 Aug 2025
Reported holdings for Timothy C. Dec in SUPERNUS PHARMACEUTICALS, INC.
Form 4 holding
Senior Vice-President & CFO
SUPERNUS PHARMACEUTICALS, INC.
- Security class
- Restricted Stock Unit
- Shares / value
- 2,500
- Estimated value
- $198,500
- Report date
- 25 Feb 2026
- Price
- $39.70
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Senior Vice-President & CFO
SUPERNUS PHARMACEUTICALS, INC.
- Security class
- Performance Share Unit
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 12 Aug 2026
- Price
- $39.11
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Senior Vice-President & CFO
SUPERNUS PHARMACEUTICALS, INC.
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 17,500
- Estimated value
- Report date
- 18 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Timothy C. Dec in SUPERNUS PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.